Biotechnology and bioengineering – Page 16
-
Research‘New era’ of designer proteins for medicines and materials
Platform computed thousands of stable designs for short proteins, up from two previous designs
-
ResearchLiving bacteria write pictures and movies to DNA
Crispr–Cas9 tool used to store information in the genome of living E. coli
-
ResearchSynthetic ‘enzyme’ matches natural counterparts for catalytic power
Nanoparticle, nucleic acid and peptide trio mimics peroxidase enzymes
-
-
FeatureDelivering gene therapy
After some well-publicised problems, gene therapy – delivering DNA into people’s cells using viruses – is booming, Anthony King finds
-
ResearchMicromotors navigate tiny biochemical lab
Resistant layer protects micromotors from protein-induced breakdown when swimming through biological fluids on lab-on-a-chip device
-
ResearchNanopipette probes cells without killing them
Scientists extract contents of individual living cells using a lipid-bilayer-coated nanopipette
-
FeatureSpinning out spider silk research
Spider silk is finding applications as diverse as tissue transplants and training shoes
-
ResearchTiny virus batteries remove water pollutant
Metal nanoparticles turn viruses into tiny batteries that reduce toxic compound in just 10 minutes
-
-
BusinessEU conditionally approves Dow–DuPont merger
To satisfy competition concerns, DuPont will swap crop protection R&D assets for FMC’s nutrition business
-
BusinessExpanding precision medicine beyond cancer
Exclusive interview with Koustubh Ranade, vice president of R&D at MedImmune
-
BusinessPacBio sues Oxford Nanopore for patent infringement
Firms spar over single-molecule gene sequencing technology
-
OpinionSafety first with gene editing
Why Darpa is creating a biosafety and biosecurity toolkit for genome editors
-
ResearchFive new artificial yeast chromosomes made
The artificial yeast genome is now around a third complete
-
BusinessCrispr patent ruling breaks deadlock
Both sides claim victory as board rules patents do not interfere with each other
-
FeatureDeal or no deal?
Clare Sansom highlights recent changes in the landscape of pharma company collaborations and acquisitions
-
BusinessUS biotech leaders protest immigration ban
Donald Trump’s suspended order would endanger America’s biotech industry if re-instated
-
BusinessCholesterol drug withdrawn in patent dispute
Ruling that Regeneron’s Praluent antibody infringes Amgen’s Repatha patent could stifle innovation
-
ResearchStrongest synthetic spider silk spun-out in the lab
Mimicking spiders’ spinning glands could cut cost of synthetic silk